Free Trial

Spectral AI (MDAI) Competitors

Spectral AI logo
$2.10 +0.04 (+1.94%)
Closing price 09/17/2025 04:00 PM Eastern
Extended Trading
$2.12 +0.02 (+1.00%)
As of 04:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MDAI vs. STIM, ELMD, CVRX, INFU, AVR, BSGM, CV, MBOT, KRMD, and SGHT

Should you be buying Spectral AI stock or one of its competitors? The main competitors of Spectral AI include Neuronetics (STIM), Electromed (ELMD), CVRx (CVRX), InfuSystem (INFU), Anteris Technologies Global (AVR), Biosig Technologies (BSGM), CapsoVision (CV), Microbot Medical (MBOT), KORU Medical Systems (KRMD), and Sight Sciences (SGHT). These companies are all part of the "medical equipment" industry.

Spectral AI vs. Its Competitors

Spectral AI (NASDAQ:MDAI) and Neuronetics (NASDAQ:STIM) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, earnings, risk, analyst recommendations, institutional ownership, media sentiment and dividends.

Neuronetics has a net margin of -43.47% compared to Spectral AI's net margin of -51.97%. Spectral AI's return on equity of 0.00% beat Neuronetics' return on equity.

Company Net Margins Return on Equity Return on Assets
Spectral AI-51.97% N/A -8.69%
Neuronetics -43.47%-156.36%-35.69%

Spectral AI has higher earnings, but lower revenue than Neuronetics. Spectral AI is trading at a lower price-to-earnings ratio than Neuronetics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Spectral AI$29.58M1.90-$15.31M-$0.69-3.04
Neuronetics$74.89M2.52-$43.71M-$1.13-2.52

Spectral AI has a beta of 0.88, suggesting that its stock price is 12% less volatile than the S&P 500. Comparatively, Neuronetics has a beta of 1.28, suggesting that its stock price is 28% more volatile than the S&P 500.

Spectral AI currently has a consensus price target of $3.50, indicating a potential upside of 66.67%. Neuronetics has a consensus price target of $7.00, indicating a potential upside of 145.61%. Given Neuronetics' higher probable upside, analysts plainly believe Neuronetics is more favorable than Spectral AI.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Spectral AI
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Neuronetics
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

67.1% of Spectral AI shares are held by institutional investors. Comparatively, 53.6% of Neuronetics shares are held by institutional investors. 30.7% of Spectral AI shares are held by insiders. Comparatively, 8.7% of Neuronetics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Neuronetics had 2 more articles in the media than Spectral AI. MarketBeat recorded 2 mentions for Neuronetics and 0 mentions for Spectral AI. Neuronetics' average media sentiment score of 1.81 beat Spectral AI's score of 0.63 indicating that Neuronetics is being referred to more favorably in the news media.

Company Overall Sentiment
Spectral AI Positive
Neuronetics Very Positive

Summary

Neuronetics beats Spectral AI on 8 of the 14 factors compared between the two stocks.

Get Spectral AI News Delivered to You Automatically

Sign up to receive the latest news and ratings for MDAI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MDAI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MDAI vs. The Competition

MetricSpectral AIMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$55.07M$6.78B$5.74B$10.30B
Dividend YieldN/A1.20%5.89%4.62%
P/E Ratio-3.0426.5876.6926.52
Price / Sales1.90191.63444.6987.66
Price / CashN/A21.7137.2260.63
Price / Book-6.564.9413.596.31
Net Income-$15.31M$178.07M$3.29B$271.37M
7 Day Performance5.53%2.87%-0.69%0.59%
1 Month Performance-0.94%5.73%3.85%6.22%
1 Year Performance79.49%17.45%81.84%28.35%

Spectral AI Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MDAI
Spectral AI
2.7526 of 5 stars
$2.10
+1.9%
$3.50
+66.7%
+72.1%$55.07M$29.58M-3.0483
STIM
Neuronetics
1.9302 of 5 stars
$2.87
-8.3%
$7.00
+143.9%
+199.4%$206.64M$111.11M-2.54180News Coverage
Positive News
ELMD
Electromed
3.9923 of 5 stars
$24.70
+3.4%
$36.25
+46.8%
+21.9%$206.22M$64M32.93160
CVRX
CVRx
2.4859 of 5 stars
$6.92
-12.1%
$14.00
+102.3%
-20.2%$205.81M$51.29M-3.30160Positive News
INFU
InfuSystem
2.5239 of 5 stars
$10.16
+1.7%
$12.50
+23.0%
+52.1%$204.06M$139.89M169.36410High Trading Volume
AVR
Anteris Technologies Global
1.5676 of 5 stars
$5.82
+4.5%
$16.50
+183.5%
N/A$200.87M$2.70M0.00138High Trading Volume
BSGM
Biosig Technologies
2.0895 of 5 stars
$6.35
+42.6%
$10.00
+57.6%
+1,962.7%$199.35M$13K0.0050News Coverage
Gap Down
High Trading Volume
CV
CapsoVision
N/A$4.33
+5.1%
$5.50
+27.0%
N/A$192.71M$12.52M0.0090Positive News
MBOT
Microbot Medical
2.3527 of 5 stars
$3.42
-15.6%
$12.00
+250.9%
+254.3%$184.46MN/A-5.9020Gap Down
KRMD
KORU Medical Systems
2.6725 of 5 stars
$3.94
+0.5%
$4.63
+17.4%
+57.8%$181.24M$36.85M-43.7880Positive News
SGHT
Sight Sciences
3.5091 of 5 stars
$3.52
+1.7%
$4.42
+25.5%
-49.9%$181.19M$79.87M-3.67210News Coverage

Related Companies and Tools


This page (NASDAQ:MDAI) was last updated on 9/18/2025 by MarketBeat.com Staff
From Our Partners